Machine learning with neuroimaging data to identify autism spectrum disorder: a systematic review and meta‑analysis
Autism spectrum disorder (ASD) is behaviourally defined by the presence of social communication deficits, and restricted repetitive behaviours.
Given the complexity and variation in the outward manifestations of ASD, neuroimaging studies provide crucial knowledge pertaining to this disease, including possible mechanisms underlying pathogenesis of the disorder.
The latest publication ‘Machine learning with neuroimaging data to identify autism spectrum disorder: asystematic review and meta‑analysis’, by Da‑Yea Song, Constantin‑Cristian Topriceanu, Denis C. Ilie‑Ablachim, Maria Kinali and Sotirios Bisdas, sheds light into the role of machine learning (ML) with neuroimaging data to provide a reliable classification of ASD.
Our meta-analysis results show the exciting prospect of applying ML in high quality brain MRI to diagnose ASD and highlight the issues required to address prior to any broad dissemination of the technique.
Full text available at https://rdcu.be/cvUbU
About Image Analysis Group (IAG)
IAG, Image Analysis Group is a unique partner to life sciences companies. IAG leverages expertise in medical imaging and the power of Dynamika™ – our proprietary cloud-based platform, to de-risk clinical development and deliver lifesaving therapies into the hands of patients much sooner. IAG provides early drug efficacy assessments, smart patient recruitment and predictive analysis of advanced treatment manifestations, thus lowering investment risk and accelerating study outcomes. IAG bio-partnering takes a broader view on asset development bringing R&D solutions, operational breadth, radiological expertise via risk-sharing financing and partnering models.
Learn more: wp1.ia-grp.com
Reach out: imaging.experts@ia-grp.com
Follow the Company: Linkedin